JOSHUA HARKEY: Open Payments
NPI 1063062586 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 40 payments from 15 companies in 2025. Trend: 2023 $66 · 2024 $507 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $113 |
| Merck Sharp & Dohme LLC | 6 | $112 |
| United Therapeutics Corporation | 3 | $98 |
| PFIZER INC. | 3 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Amgen Inc. | 2 | $31 |
Products named: Wegovy, Kerendia, Tyvaso, VERQUVO, JARDIANCE, LEQVIO, ELIQUIS, CAMZYOS.
Industry payments across GA — which companies pay providers there.
